BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 38.8% in December

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 191,200 shares, a growth of 38.8% from the December 15th total of 137,800 shares. Based on an average daily volume of 98,300 shares, the short-interest ratio is presently 1.9 days.

BioStem Technologies Trading Up 1.9 %

BSEM traded up $0.29 during trading on Wednesday, hitting $15.63. 84,832 shares of the company’s stock were exchanged, compared to its average volume of 49,659. BioStem Technologies has a 1 year low of $4.41 and a 1 year high of $28.26. The stock has a 50 day moving average price of $15.45 and a 200 day moving average price of $12.60. The firm has a market cap of $260.30 million, a P/E ratio of 22.99 and a beta of -0.53.

BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.01. The business had revenue of $82.56 million for the quarter, compared to analysts’ expectations of $78.22 million. Analysts forecast that BioStem Technologies will post 1.41 earnings per share for the current fiscal year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.